auction?22 Aug 2007 11:32
someone with more detailed info can no doubt confirm this - but I think Bid and Offer are both at 34.0p on ASM. These shares have been oversold and are now being snapped up with such fantastic news regarding ASA404's brilliant Phase II results on lung cancer:-
Antisoma says phase II lung cancer drug trial reports positive results
LONDON (Thomson Financial) - Cancer drug developer Antisoma PLC said the phase II trial of its ASA404 drug has produced positive final results and added that the trial has shown one of the largest increases in median survival ever reported in lung cancer.
'These positive results strongly support our earlier trial findings, which showed that adding ASA404 to chemotherapy improves survival in patients with lung cancer,' Antisoma's chief operating officer Dr Ursula Ney said.
Antisoma's partner, Novartis, plans to start enrolment of patients into a phase III trial early in 2008, the company added.